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Breast cancer belongs to the most common malignancy
diagnosed in women. The major inherited susceptibilities
to breast cancer are germline mutations in mutations in
high risk genes, eg. BRCA1, BRCA2, BRIP, PALB2,
RAD51C, RAD51D (5-10%), mutations in moderate risk
genes, eg. CHEK2, ATM, NBS1 (10-20%) which however,
explain only a small number of breast cancer cases. The
latter are alterations in low risk genes and other possible
changes in genome, eg. constitutional methylations of
BRCA1.
Genome – Wide Association Study (GWAS) was
thought to help in identification of low risk alleles asso-
ciated with the risk of particular disease. Up to know 14
GWAS conducted on Caucasian and 6 GWAS on Asian
population (http://www.genome.gov/gwastudies/index.
cfm?pageid=26525384#searchForm) have been performed
on breast cancer cases and 21 variants associated with
modest risk of BC (OR <1.3) have been identified.
In 2005 have been initiated Breast Cancer Association
Consortium (BCAC), an international multidisciplinary
forum of investigators interested in the inherited risk of
breast cancer. The aim of the consortium is to combine
data from many studies in order to identify genes/SNPs
and provide a reliable assessment of the breast cancer
risks. Currently the BCAC gathers 69 centers from 29
countries, including Poland, and has access to demo-
graphic, clinical and epidemiological data from over
76,000 breast cancer patients and 83,000 unaffected
women. In GWAS performed by BCAC 14 SNPs have
been identified to be associated with modest risks of breast
cancer(per-allele ORs<1.3).
The aim of this study was to assess usefulness of SNPs
identified in BCAC GWAS in diagnostics of breast cancer
risk in Polish population.
We found that 6 out of 14 SNPs identified in BCAC
GWAS were associated with breast cancer risk in Polish
patients. Four additional SNPs have been found to be
associated with moderate risk of breast cancer in Polish
study. Overall, out of 10 SNPs strongest in Polish study 3
seem to be valuable markers for breast cancer diagnostics
in Poland: OR 1.91, 95%CI 1.39-2.65, p 0.0001 for carriers
of 2 risk alleles and OR 3.2, 95%CI 1.87-5.47, p<0.0001 for
carriers of 3 risk allele.
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